Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KDNY | PTCT | CPRX | ||
| Company | Chinook Therapeutics Inc | Ptc Therapeutics | Catalyst Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.31 | 44.77 | 21.27 | ||
| High | 40.51 | 47.42 | 21.41 | ||
| Low | 40.30 | 44.74 | 21.01 | ||
| Last | 40.39 | 46.24 | 21.27 | ||
| Change | +0.09 | +0.99 | -0.19 | ||
| % Change | +0.22% | +2.19% | -0.89% | ||
| Volume | 4,924,900 | 1,431,600 | 1,753,300 | ||
| 20-Day Average Volume | 2,629,690 | 916,160 | 916,435 | ||
| Previous Close | 40.30 | 45.25 | 21.46 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.61 | 47.20 | 21.76 | ||
| 20-Day Raw Stochastic | 92.73% | 30.65% | 16.27% | ||
| 20-Day Relative Strength | 77.95% | 53.19% | 47.67% | ||
| Weighted Alpha | +55.60 | +75.76 | +33.38 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.25% since 08/03/23 | -0.28% since 12/13/24 | -0.51% since 12/13/24 | ||
| Low | 40.25 on 08/04/23 | 44.30 on 12/18/24 | 21.01 on 12/20/24 | ||
| High | 40.51 on 08/10/23 | 48.77 on 12/16/24 | 22.67 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +3.30% since 07/10/23 | +10.20% since 11/20/24 | +0.57% since 11/20/24 | ||
| Low | 38.86 on 07/21/23 | 41.21 on 11/21/24 | 20.87 on 11/21/24 | ||
| High | 40.51 on 08/10/23 | 54.16 on 12/03/24 | 23.02 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +74.62% since 05/10/23 | +26.20% since 09/20/24 | +2.31% since 09/20/24 | ||
| Low | 19.20 on 05/16/23 | 34.57 on 10/07/24 | 19.35 on 09/30/24 | ||
| High | 40.51 on 08/10/23 | 54.16 on 12/03/24 | 24.27 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +67.39% since 02/10/23 | +38.90% since 06/20/24 | +40.12% since 06/20/24 | ||
| Low | 18.34 on 05/02/23 | 28.72 on 06/28/24 | 14.75 on 06/26/24 | ||
| High | 40.51 on 08/10/23 | 54.16 on 12/03/24 | 24.27 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,900,204 | 3,566,260 | 2,536,937 | ||
| Shares Outstanding, K | 71,805 | 77,125 | 119,273 | ||
| Annual Sales | 6,130,000 | 937,820,000 | 398,200,000 | ||
| Annual Net Income | -187,870,000 | -626,600,000 | 71,410,000 | ||
| Last Quarter Sales | 1,830,000 | 196,790,000 | 128,700,000 | ||
| Last Quarter Net Income | -60,180,000 | -106,650,000 | 43,880,000 | ||
| 60-Month Beta | 0.34 | 0.63 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 08/07/23 | -1.39 on 11/07/24 | 0.57 on 11/06/24 | ||
| Latest Earnings Date | 08/14/23 | 11/07/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.60 | ||